Sztein MB - Search Results

1

Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.

El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA. El Sahly HM, et al. Among authors: sztein mb. Vaccine. 2009 Aug 6;27(36):4905-11. doi: 10.1016/j.vaccine.2009.06.036. Epub 2009 Jun 28. Vaccine. 2009. PMID: 19567246 Free PMC article. Clinical Trial.

2

An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

Pasetti MF, Cuberos L, Horn TL, Shearer JD, Matthews SJ, House RV, Sztein MB. Pasetti MF, et al. Among authors: sztein mb. Vaccine. 2008 Mar 25;26(14):1773-85. doi: 10.1016/j.vaccine.2008.01.005. Epub 2008 Jan 29. Vaccine. 2008. PMID: 18308432 Free PMC article.

3

Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Mulligan MJ, Stapleton JT, Keitel WA, Frey SE, Chen WH, Rouphael N, Edupuganti S, Beck A, Winokur PL, El Sahly HM, Patel SM, Atmar RL, Graham I, Anderson E, El-Kamary SS, Pasetti MF, Sztein MB, Hill H, Goll JB; DMID 08-0006 Tularemia Vaccine Study Group. Mulligan MJ, et al. Among authors: sztein mb. Vaccine. 2017 Aug 24;35(36):4730-4737. doi: 10.1016/j.vaccine.2017.07.024. Epub 2017 Jul 24. Vaccine. 2017. PMID: 28750854 Free PMC article. Clinical Trial.

4

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.

Anderson RJ, Pasetti MF, Sztein MB, Levine MM, Noriega FR. Anderson RJ, et al. Among authors: sztein mb. Vaccine. 2000 Apr 28;18(21):2193-202. doi: 10.1016/s0264-410x(00)00025-6. Vaccine. 2000. PMID: 10717338

5

A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.

Pasetti MF, Pickett TE, Levine MM, Sztein MB. Pasetti MF, et al. Among authors: sztein mb. Vaccine. 2000 Aug 1;18(28):3208-13. doi: 10.1016/s0264-410x(00)00142-0. Vaccine. 2000. PMID: 10869765

6

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.

Pasetti MF, Levine MM, Sztein MB. Pasetti MF, et al. Among authors: sztein mb. Vaccine. 2003 Jan 17;21(5-6):401-18. doi: 10.1016/s0264-410x(02)00472-3. Vaccine. 2003. PMID: 12531639 Review.

7

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Chen WH, Cross AS, Edelman R, Sztein MB, Blackwelder WC, Pasetti MF. Chen WH, et al. Among authors: sztein mb. Vaccine. 2011 Apr 5;29(16):2865-73. doi: 10.1016/j.vaccine.2011.02.017. Epub 2011 Feb 23. Vaccine. 2011. PMID: 21352939 Free PMC article. Clinical Trial.

8

Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector.

Simon JK, Carter M, Pasetti MF, Sztein MB, Kotloff KL, Weniger BG, Campbell JD, Levine MM. Simon JK, et al. Among authors: sztein mb. Vaccine. 2011 Nov 28;29(51):9544-50. doi: 10.1016/j.vaccine.2011.09.097. Epub 2011 Oct 8. Vaccine. 2011. PMID: 21986218 Clinical Trial.

9

Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B.

Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB. Wahid R, et al. Among authors: sztein mb. Clin Vaccine Immunol. 2014 Mar;21(3):427-34. doi: 10.1128/CVI.00786-13. Epub 2014 Jan 15. Clin Vaccine Immunol. 2014. PMID: 24429069 Free PMC article. Clinical Trial.

10

A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.

Bernstein DI, Pasetti MF, Brady R, Buskirk AD, Wahid R, Dickey M, Cohen M, Baughman H, El-Khorazaty J, Maier N, Sztein MB, Baqar S, Bourgeois AL. Bernstein DI, et al. Among authors: sztein mb. Vaccine. 2019 Jan 21;37(4):602-611. doi: 10.1016/j.vaccine.2018.12.011. Epub 2018 Dec 15. Vaccine. 2019. PMID: 30563789 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page